Table 1.
Reference | donor or sample numbers (% male)1 | n samples/tissue males | n samples/tissue females | n tissues | Data source | cutoff for differential expression | primary assessment (Table 2) | total genes analyzed | total sex-biased genes | % genes sex-biased in 1 or more tissues |
---|---|---|---|---|---|---|---|---|---|---|
(Mele et al., 2015) | 175 donors (63%) | 14–99 | 11–57 | 43 | GTEx pilot set | False discovery rate (FDR) <0.05 | Any gene with sex bias | 20,110 protein or non-coding genes | 753 (mostly breast) | 0.1– 0.23% per tissue |
(Mayne et al., 2016) | 2500 samples (68%) | 5–622 | 7–289 | 15 | Compiled microarray data | FDR < 0.05 | Any gene with sex bias | not directly provided | 163–1818 genes | 32% autosomal |
(Gershoni & Pietrokovski, 2017) | 544 donors (64%) | Number of samples per tissue not specified | NA | 45 | GTEx v6 | p <0.05, fold change ≥ 2 | Any gene with sex bias, excluded mammary gland | 18,670 protein coding genes only | “just over” 6500 | 35% total |
(Tukiainen et al., 2017) | 449 donors (65%) | 43–228 | 26–133 | 29 | GTEx v6 | FDR < 0.01 | Any X chromosome gene with sex bias, excluded mammary gland | 681 protein-coding or long non-coding genes on the X chromosome | 4% inactivated, 6% variable inactivation, 48% escape genes | |
(Naqvi et al., 2019) | 740 samples selected (67%) | 17–83 | 9–36 | 12 | GTEx v6p | ≥ 1.05 fold change in 4/5 species | Any gene with sex bias conserved across mammals | 12,939 protein-coding orthologs only | 3161 | 24% total |
(Kassam et al., 2019) | 617 donors (73%) | 80–491 | 23–125 | 40 | GTEx v7 | Bonferroni corrected significance threshold of PTSSD≤1.58×10−6 | Any gene with sex bias, excluded mammary, pituitary, and minor salivary glands | 23,608 mean protein or non-coding genes per tissue | 131 per tissue | 0.6 % per tissue |
(Lopes-Ramos et al., 2020) | 548 donors (66%) | 82–290 | 36–162 | 29 | GTEx v6 | FDR <0.05, fold change ≥ 1.5 | Any gene predicted to be targeted by sex-biased gene regulatory network | 30,243 protein or non-coding genes | Overall median 64 differentially expressed genes per tissue (4,181 in breast); overall median 169 differentially targeted per tissue (25,994 in breast) | 0.2 % differentially expressed per tissue; 0.6 % differentially targeted per tissue |
(Oliva et al., 2020) | 838 donors (61–78%) | 78–469 | 33–237 | 44 | GTEx v82 | Local False Sign Rate (LFSR) ≤ 0.05 | Any gene with sex bias | 35,431 protein or non-coding genes | 473 to 4558 per tissue | 1.3% to 12.9% per tissue |
(Hartman et al., 2020) | 14 boy-girl newborn twins (50%), 172 adult (75%) | 7/newborn, 129/adult | 7/newborn, 43/adult | 2 | Newborns: RNA seq, Adults: microarray GSE30169 | “intrinsic” p-value < 0.1 at birth and < 0.05 in adults; “acquired” p-value > 0.5 at birth and < 0.05 in adults; any fold change | Any gene with sex bias in HUVEC or HAEC3 | 18630 protein or non-coding genes (same genes queried in RNA seq & microarray) | 2528 at birth in boy/girl twins, 1,798 in adults, 268 in both | 25% of newborn and 14% of adult EC transcriptome |
(Hartman, Mokry, et al., 2021) | >700 donors (59–69%) | 116–538 | 82–256 | 24 | GTEx v8 | FDR<0.1, fold change ≥ 2 with coexpression in more than 20 permutations of the data | Any gene with sex bias. More than 80 samples of each type and sex | 13,787 protein or non-coding genes | 4062 | 29.5% total |
The papers varied widely in how sample numbers were reported. The numbers, if present, were often buried deeply in supplemental files.
v8 is the latest GTEx Release (dbGaP Accession phs000424.v8.p2) with 54 tissues from 636 male and 312 female donors (85% white). Details are here: https://www.gtexportal.org/home/tissueSummaryPage
HUVEC: human umbilical vein endothelial cells; HAEC: human adult aortic endothelial cells